Saltar ao contenido
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Idioma
Todos os campos
Title
Autor
Subject
Número de Clasificación
ISBN/ISSN
Tag
Buscar
Avanzado
Allogeneic stem cell transplan...
Citar
Text this
Enviar este rexistro por email
Imprimir
Exportar rexistro
Exportar a RefWorks
Exportar a EndNoteWeb
Exportar a EndNote
Permanent link
Allogeneic stem cell transplantation for lymphoproliferative disease using BEAM-Campath conditioning: An effective regime with low procedure-related toxicity.
Detalles Bibliográficos
Main Authors:
Cull, G
,
Haynes, A
,
Byrne, J
,
Carter, G
,
Miflin, G
,
Hale, G
,
Waldmann, H
,
Russell, N
Formato:
Journal article
Publicado:
1999
Existencias
Descripción
Títulos similares
Staff View
Títulos similares
Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH conditioning: an effective regimen with low procedure-related toxicity.
por: Cull, G, et al.
Publicado: (2000)
Evaluation of non-myeloablative conditioning combining beam with in vivo pre-transplant Campath-IG for allogeneic transplantation in patients with lymphoma.
por: Russell, N, et al.
Publicado: (1999)
T cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation.
por: Hale, G, et al.
Publicado: (1988)
Risks of developing Epstein-Barr virus-related lymphoproliferative disorders after T-cell-depleted marrow transplants. CAMPATH Users.
por: Hale, G, et al.
Publicado: (1998)
Alemtuzumab (Campath-1H) in allogeneic stem cell transplantation: where do we go from here?
por: Chakrabarti, S, et al.
Publicado: (2004)